Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level

Summary

This is a single-Center, randomized, double-Blind, placebo-controlled, multiple ascending-dose Phase I trail.

Timeline

Start

2017-07-04

Primary completion

2018-02-15

Completion

2018-02-15

Drugs

Indications